27 days to first decision for reviewed manuscripts only
19 days to first decision for all manuscripts
76 days from submission to acceptance
18 days from acceptance to publication
Recent studies indicate that abnormalities of the alpha-chain of the interleukin-3 receptor (IL-3RA or CD123) are frequently observed in some leukemic disorders and may contribute to the proliferative advantag...
Citation: Biomarker Research 2014 2:4